Rare diseases are only rare if you don’t live with one.®
There are over 6,000 rare diseases and more than 300 million patients suffering from those conditions.
Quoin Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases.
Team
Quoin’s executive management and board members are highly experienced business leaders with a track record of successful development and commercialization of therapeutic products for previously unmet medical needs.
Pipeline
Quoin has an innovative pipeline of development stage products that will address unmet needs for a number of rare and orphan diseases.
Investors
View our latest news, download presentations, and sign up for alerts to stay up to date on Quoin Pharmaceuticals.